About Benjamin Scruggs
Form D filings for Veralox Therapeutics from 2021 to 2023 list Benjamin Scruggs as director.
Benjamin Scruggs first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Scruggs in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Scruggs works with at each company, as listed on that company's latest Form D.
Veralox Therapeutics Inc. · Form D, Jun 21, 2023
MK
Megan Krench
Director
AM
Alex Martin
Director
JS
Jamie Stiff
Director
KE
Katie Ellias
Director
JM
Jonathan Mow
Chief Executive Officer and director